RDF/XML JSON-LD N3/Turtle RDF/JSON
Author profile at the institutional portal

Colomer Bosch, Ramon ramon.colomer@uam.es

Medicina / Universidad Autónoma de Madrid

Publications

Efficacy and CNS progression analysis from the randomized phase 2 trial of neratinib+ paclitaxel vs trastuzumab+ paclitaxel as first-line treatment for HER2+ metastatic breast …

  • Ahmad Awada
  • Ramon Colomer
  • Igor Bondarenko
  • Kenichi Inoue
  • Rajendra A Badwe
  • Georgia Demetriou
  • Xiaojia Wang
  • Vitaly Smirnov
  • Soo-Chin Lee
  • Ajay O Mehta
  • Sung-Bae Kim
  • Zhen-Zhou Shen
  • Thomas Denis Bachelot
  • Chanchal Goswami
  • SVS Deo
  • Ron Bose
  • Alvin Wong
  • Feng Xu
  • Richard Bryce
  • Lisa A Carey
... View more Collapse

Journal Of Clinical Oncology (p. 610-610) - 1/1/2015

  • ISSN 0732183X
  • iMarina

It is not time to stop progesterone receptor testing in breast cancer

  • R Colomer
  • M Beltran
  • J Dorcas
  • H Cortes-Funes
  • J Hornedo
  • V Valentin
  • C Vargas
  • C Mendiola
  • E Ciruelos
... View more Collapse

Journal Of Clinical Oncology (p. 3868-3869) - 1/12/2005

10.1200/jco.2005.05.203 View at source

  • ISSN 0732183X

IsMetastatic Disease the Best Setting for Cost-Effectiveness Studies?

  • Ramon Colomer
  • Tomás Pascual
  • Joan Albanell

Journal Of Clinical Oncology (p. 3226-+) - 10/9/2016

10.1200/jco.2016.68.2534 View at source

  • ISSN 0732183X

Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: Results of a multivariate analysis

  • Gomez, H
  • Hidalgo, M
  • Casanova, L
  • Colomer, R
  • Pen, DLK
  • Otero, J
  • Rodriguez, W
  • Carracedo, C
  • Cortes-Funes, H
  • Vallejos, C;
... View more Collapse

Journal Of Clinical Oncology (p. 2065-2069) - 1/1/1998

10.1200/jco.1998.16.6.2065 View at source

  • ISSN 0732183X

Intensive Loading Dose of Trastuzumab Achieves Higher-Than-Steady-State Serum Concentrations and Is Well Tolerated

  • Leyland-Jones, Brian
  • Colomer, Ramon
  • Trudeau, Maureen E.
  • Wardley, Andrew
  • Latreille, Jean
  • Cameron, David
  • Cubedo, Ricardo
  • Al-Sakaff, Nedal
  • Feyereislova, Andrea
  • Catalani, Olivier
  • Fukushima, Yumi
  • Brewster, Michael
  • Cortes, Javier;
... View more Collapse

Journal Of Clinical Oncology (p. 960-966) - 20/2/2010

10.1200/jco.2009.23.1910 View at source

  • ISSN 0732183X

Does HER-2 status predict only a decreased response to hormone therapy in advanced breast cancer, or does it also predict the extent of metastatic disease?

  • Beltran, M
  • Colomer, R;

Journal Of Clinical Oncology (p. 4605-4605) - 1/12/2002

10.1200/jco.2002.99.191 View at source

  • ISSN 0732183X

Access to specialized cancer care and clinical trials for cancer patients from non-urban areas is facilitated by a Cancer Network organization

  • J Brunet
  • B Martin
  • S Del Barco
  • I Juez
  • A García
  • G Vin?as
  • X Herna?ndez
  • M Arnedos
  • JM Borra?s
  • R Colomer
... View more Collapse

Journal Of Clinical Oncology (p. 16006-16006) - 1/1/2006

  • ISSN 0732183X
  • iMarina

Prediction of Response to Targeted Therapies in Lung Cancer Using Dynamic Imaging: Still Far From Clinical Implementation

  • Quintela-Fandino, Miguel
  • Colomer, Ramon;

Journal Of Clinical Oncology (p. 3716-3718) - 20/9/2011

10.1200/jco.2011.37.1427 View at source

  • ISSN 0732183X

Liposomal doxorubicin (M) plus gemcitabine (G) as first line treatment in metastatic breast carcinoma: A phase I-II study

  • R Colomer
  • I Tusquets
  • L Calvo
  • J Dorca
  • E Adrover
  • P Sanchez-Rovira
  • J Rifa
  • J De La Haba
  • JA Virizuela
  • M Beltran
... View more Collapse

Journal Of Clinical Oncology (p. 10651-10651) - 1/1/2006

  • ISSN 0732183X
  • iMarina

Validation of the 2001 St Gallen risk categories for node-negative breast cancer using a database from the Spanish Breast Cancer Research Group (GEICAM)

  • Colomer, R
  • Vinas, G
  • Beltran, M
  • Izquierdo, A
  • Lluch, A
  • Llombart-Cussac, A
  • Alba, E
  • Munarriz, B
  • Martin, M;
... View more Collapse

Journal Of Clinical Oncology (p. 961-962) - 1/12/2004

10.1200/jco.2004.99.143 View at source

  • ISSN 0732183X

Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …

  • Chau Dang
  • Michael S Ewer
  • Suzette Delaloge
  • Jean-Marc Ferrero
  • Mark Verrill
  • Ramon Colomer
  • Claudia Vieira
  • Luis de la Cruz Merino
  • Jennifer Lucas
  • Theresa L Werner
  • Hannah Douthwaite
  • Denise Bradley
  • Maeve Waldron-Lynch
  • Jennifer Eng-Wong
  • Sandra M Swain
... View more Collapse

1/1/2018

  • iMarina

Tratado de oncología

  • Hernán Cortés-Funes
  • Ramón Colomer Bosch
  • Emilio Alba Conejo

1/1/2009

  • ISBN 9788492620166
  • iMarina

Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  • J Rogado
  • MD Fenor De La Maza
  • V Pacheco-Barcia
  • JM Serra
  • P Toquero
  • B Vera
  • A Ballesteros
  • R Mondejar
  • O Donnay
  • B Obispo
  • R Colomer
  • JM Sanchez-Torres
... View more Collapse

1/1/2017

  • iMarina

Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study

  • J Albanell
  • E Ciruelos
  • R Colomer
  • J De la Haba
  • M Martin
  • De Salas-Cansado
  • B Munoz-Molina
  • C Tournier
  • P Thuresson
  • W Schleich
... View more Collapse

1/1/2015

  • iMarina

Tratamiento hormonal del cáncer

  • Ramón Colomer Bosch
  • M L Amador
  • J González Cortijo
  • MV Tornamira

Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003

  • iMarina

Fatty acid metabolism in cancer cell survival: A new anti-cancer target

  • Porta, Rut
  • Colomer, Ramon
  • Puig, Teresa;

Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011

  • iMarina

Medicina de precisión en oncología: Éxitos y perspectivas bioéticas

  • Ramón Colomer Bosch

Bioética Y Cáncer (p. 17-26) - 1/1/2020

  • iMarina

Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with …

  • M Marangolo
  • I Lang
  • C Beato
  • R Colomer
  • L Ukarma

(p. 388-388) - 1/1/2005

  • iMarina

ESTIMATED COSTS OF LOCOREGIONAL AND METASTATIC RECURRENCES IN PATIENTS WITH HER2+BREAST CANCER IN SPAIN

  • Albanell, J.
  • Ciruelos, E.
  • De la Haba, J.
  • Martin, M.
  • Munoz-Molina, B.
  • De Salas-Cansado, M.
  • Colomer, R.;
... View more Collapse

Value In Health (p. A729-A729) - 1/1/2016

10.1016/j.jval.2016.09.2190 View at source

  • ISSN 10983015

PERFORMANCE AND ADEQUACY OF PATIENT-PERSPECTIVE CRITERIA IN THE ASSESSMENT OF TEST-RETEST RELIABILITY: THE CASE OF THE PERFORM QUESTIONNAIRE

  • Baro, E
  • Rodriguez, C
  • Gascon, P
  • Garcia-Mata, J
  • Colomer, R
  • Cassinello, J
  • Carulla, J
  • Valentin, V
  • Gasquet, J A
... View more Collapse

Value In Health (p. A486-A486) - 1/1/2008

10.1016/s1098-3015(10)66620-x View at source

  • ISSN 10983015

Sensitivity to change of the perform questionnaire (PQ) in cancer patients reporting improvement or deterioration of their cancer-related fatigue

  • Baro, E
  • Cassinello, J
  • Caruiia, J
  • Valentin, V
  • C, Rodriguez
  • Gascon, P
  • J, Garcia-Mata
  • Colomer, R
  • Gasquet, J A
... View more Collapse

Value In Health (p. A343-A344) - 1/1/2007

10.1016/s1098-3015(10)65226-6 View at source

  • ISSN 10983015

Using psychometric and clinimetric techniques to select items for use in a new instrument to measure cancer-related fatigue

  • Baro, E
  • Carulla, J
  • Valentin, V
  • Rodriguez, C
  • Gascon, P
  • Garcia-Mata, J
  • Colomer, R
  • Cassinello, J
  • Herdman, M
  • Gasquet, J A
  • Sanchez, J
... View more Collapse

Value In Health (p. A203-A203) - 1/1/2006

10.1016/s1098-3015(10)63204-4 View at source

  • ISSN 10983015

CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN

  • Ciruelos, E.
  • Alba, E.
  • Lopez, R.
  • Lluch, A.
  • Martin, M.
  • Arroyo, I
  • Navarro, B.
  • Carcedo, D.
  • Colomer, R.
  • Albanell, J.;
... View more Collapse

Value In Health (p. S18-S18) - 1/1/2018

10.1016/j.jval.2018.09.102 View at source

  • ISSN 10983015

COST-UTILITY ANALYSIS OF NEOADJUVANT CHEMOTHERAPY WITH PERTUZUMAB, TRASTUZUMAB AND DOCETAXEL IN PATIENTS WITH HER2+BREAST CANCER IN SPAINCO ST-UTILITY ANALYSIS OF NEOADJUVANT CHEMOTHERAPY WITH PERTUZUMAB, TRASTUZUMAB AND DOCETAXEL IN PATIENTS WITH HER2+BREAST CANCER IN SPAIN

  • Colomer, R.
  • Ciruelos, E.
  • De la Haba, J.
  • Martin, M.
  • De Salas-Cansado, M.
  • Munoz-Molina, B.
  • Albanell, J.;
... View more Collapse

Value In Health (p. A740-A740) - 1/1/2016

10.1016/j.jval.2016.09.2249 View at source

  • ISSN 10983015

TREATMENT RATES IN PATIENTS WITH HER2+METASTATIC BREAST CANCER AND THE FACTORS INFLUENCING TREATMENT DECISION

  • Colomer, R.
  • Hall, P.
  • Szkultecka-Debek, M.
  • Bondi, R.
  • Flinois, A.
  • Auziere, S.
  • Le Cleach, J.;
... View more Collapse

Value In Health (p. A764-A765) - 1/1/2016

10.1016/j.jval.2016.09.2386 View at source

  • ISSN 10983015

RESPONSE TO TARGETED THERAPY AND HEALTHCARE RESOURCE UTILIZATION (HRU): A EUROPEAN RETROSPECTIVE CHART REVIEW STUDY IN PATIENTS WITH HER2+METASTATIC BREAST CANCER

  • Colomer, R.
  • Hall, P.
  • Szkultecka-Debek, M.
  • Bondi, R.
  • Flinois, A.
  • Le Cleach, J.;

Value In Health (p. A742-A742) - 1/1/2016

10.1016/j.jval.2016.09.2260 View at source

  • ISSN 10983015

USEFULNESS OF CA-15.3 SERIC LEVELS IN CLINICAL-PRACTICE

  • RUIBAL, A
  • COLOMER, R
  • ROSELL, M
  • GRIS, JM;

Tumour Biology (p. 315-315) - 1/1/1986

  • ISSN 02895447
  • iMarina

[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]

  • Sanchez-Munoz, A
  • Gravalos Castro, C
  • Colomer Bosch, R
  • Garcia Velasco, A
  • Garcia, J P
  • Cortes-Funes, H

Revista Clinica Espanola (p. 597-598) - 1/1/2003

10.1157/13053731

  • ISSN 15781860
  • iMarina

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.

  • Hitt, R
  • Paz-Ares, L
  • Hidalgo, M
  • Colomer, R
  • Brandariz, A
  • Pena, M
  • Alvarez-Vicent, J
  • Hornedo, J
  • Cortes-Funes, H;
... View more Collapse

Seminars In Oncology (p. S19-20) - 1/12/1997

  • ISSN 00937754
  • iMarina

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

  • Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators

Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020

10.1200/jco.20.02514

  • ISSN 0732183X
  • iMarina

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization

  • Arranz, R.
  • García-Alfonso, P.
  • Sobrino, P.
  • Zamora, P.
  • Carrión, R.
  • García-Laraña, J.
  • Pérez, G.
  • López, J.
  • Lavilla, E.
  • Lozano, M.
  • Rayón, C.
  • Colomer, R.
  • González Barón, M.
  • Flores, E.
  • Pérez-Manga, G.
  • Fernández-Rañada, J.M.
... View more Collapse

Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998

Editor: American Society of Clinical Oncology

10.1200/jco.1998.16.4.1538 View at source

  • ISSN 0732183X
  • ISSN/ISBN 0732-183X

A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer

  • Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R

Clinical Breast Cancer (p. 286-91) - 1/1/2003

10.3816/cbc.2003.n.034 View at source

  • ISSN 15268209

Desestabilización estructural de la adicción a oncogenes en cáncer de mama mediante el bloqueo de la sintasa de ácidos grasos

  • Colomer Bosch, Ramon (Investigador principal (IP))

Period: 01-01-2012 - 31-12-2014

  • iMarina

Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas

  • Rebeca Mondéjar Solís (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia

28/1/2021

  • iMarina

Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís

1/1/2016

  • iMarina

El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Javier Abel Menéndez Menéndez (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo

1/1/2016

  • iMarina

Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín

1/1/2007

  • iMarina

Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia

1/1/2004

  • iMarina

Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo

1/1/2003

  • iMarina

Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz

1/1/2002

  • iMarina

Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez

1/1/2001

  • iMarina

Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater

1/1/1996

  • iMarina

This researcher has no patents or software licenses.

Last data update: 4/24/24 1:20 PM